This pooled analysis of 2 randomized clinical trials evaluates the association of DNA mismatch repair status with disease-free survival in patients with stage III colon cancer treated with FOLFOX.
from Cancer via ola Kala on Inoreader http://ift.tt/2zlmyBe
via IFTTT
Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου